Molecule could help treat insulin resistance

Diabetes Call for further research into apelin treatment in diabetes after positive results in mice.

Insulin resistance in diabetes and other metabolic disorders could be treated by a naturally occurring molecule with insulin-like effects, studies by French researchers suggest.

The mechanisms that regulate apelin, a peptide found in a variety of tissues in the body and in the bloodstream, and those that regulate insulin are known to be closely related, but researchers had not previously looked at how apelin affects glucose metabolism in the body.

Professor Isabelle Castan-Laurell and colleagues from the University of Toulouse injected mice intravenously with apelin and found that it rapidly reduced glucose levels in the blood.

They then went on to examine how apelin affected the way that glucose was metabolised in the body. They found that apelin increased glucose turnover and, in response, liver tissue adjusted its glucose production so that normal blood glucose levels were maintained.

In addition, apelin was able to increase insulin-stimulated glucose transport, suggesting that the effects of apelin and insulin are mediated by different mechanisms and can be additive.

'Apelin could represent a promising target in the management of insulin resistance,' Professor Castan-Laurell said.

'Improvement of insulin sensitivity and reduction of blood glucose levels are expected goals for the treatment of type-2 diabetes. We demonstrated that acute injection of apelin was able to improve glucose tolerance in insulin-resistant mice and to increase glucose utilisation in white adipose tissue, skeletal muscles and the heart.'

The effect of long-term treatment with apelin will now need to be studied to provide further insight into the precise role the peptide plays in treating insulin resistance, the researchers said.

The findings may also have wider benefits, they pointed out. 'The contribution of apelin should yield new insights into the physiology and physiopathology of glucose and lipid metabolism.'

tom.moberly@haymarket.com

Cell Metabolism 2008; 8: 437-45

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs to place orders for COVID-19 vaccine as NHS targets second dose at 12 weeks, says Stevens

GPs to place orders for COVID-19 vaccine as NHS targets second dose at 12 weeks, says Stevens

GP-led vaccination sites will be able to place orders for COVID-19 vaccine supplies...

RCGP and Marie Curie urge GPs to adopt end of life care standards for care homes

RCGP and Marie Curie urge GPs to adopt end of life care standards for care homes

Best practice standards to help GPs improve end of life care in care homes despite...

Thank your team for their inspirational work during the COVID-19 pandemic #myGPteam

Thank your team for their inspirational work during the COVID-19 pandemic #myGPteam

Never has teamwork in general practice been more important than during the COVID-19...

BMA mourns 'dark death toll' as UK passes 100,000 COVID-19 deaths

BMA mourns 'dark death toll' as UK passes 100,000 COVID-19 deaths

More than 100,000 people have now died from COVID-19 in the UK, five times the death...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Viewpoint: End-of-life care in care homes goes well beyond COVID-19

Viewpoint: End-of-life care in care homes goes well beyond COVID-19

Best practice standards for GPs and teams caring for older people in care homes -...